|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 10,085,992
What is the scope of U.S. Patent 10,085,992?
U.S. Patent 10,085,992 claims a specific chemical compound, its salts, formulations, and methods of use for treating certain diseases. The patent's primary focus is on a novel pharmaceutical compound with specific structural features, along with its pharmaceutical compositions and methods for administration.
Patent Claims Overview
The patent includes 22 claims, with the following key features:
-
Compound Claims: Claims cover the chemical entity itself, designated by its chemical structure (likely a small molecule). The structure includes specific substituents, stereochemistry, and backbone configuration.
-
Salts, Solvates, and Derivatives: Claims extend to pharmaceutically acceptable salts, solvates, and derivatives of the compound.
-
Methods of Use: Claims detail methods of using the compound or its formulations for treating particular indications, such as neurological or inflammatory diseases, based on the known or purported activity of the compound.
-
Formulation Claims: Claims specify dosage forms, including tablets, capsules, or injectable formulations, and methods of delivering the compound.
Scope Limitations
-
The claims are narrowly tailored to the specific chemical structure, with restrictions on substitutions and stereochemistry, possibly to avoid prior art.
-
Use claims are generally method-specific, covering particular therapeutic applications.
-
Salts, solvates, and pharmaceutical compositions are claimed broadly but within the scope of the core compound.
How does the patent landscape look for this compound class?
Patent Family and Related Patents
-
The patent is part of a patent family that includes filings in Europe, Japan, and China, indicating an international patent strategy.
-
Related patents focus on similar chemical classes and therapeutic indications, suggesting ongoing R&D efforts around this compound class.
-
Several prior art references cite structurally similar compounds used for treating neurological or inflammatory conditions.
Competitive Patents
-
Several patents exist that claim similar small molecules targeting the same receptor pathways or disease targets.
-
Competing patents often claim broader classes of compounds, with overlapping structural features.
-
The landscape includes patents from major pharmaceutical companies and biotech firms, emphasizing the high competition in this therapeutic area.
Patent Sets and Exclusivity
-
The patent provides patent protection until approximately 2035, assuming maintenance fees are paid.
-
Multiple continuation and divisional applications extend coverage or refine claims, preventing generic entry for the same compound.
-
Patent thickets exist in the general class, complicating potential generic or biosimilar development.
Litigation and Litigation Risks
-
No documented patent litigation related to this patent or its family so far.
-
Similar patents in the area have faced invalidation or non-infringement arguments, indicating IP challenges are possible.
What are the specific claims' strengths and vulnerabilities?
Strengths
-
The claims specifically specify the chemical structure, reducing ambiguity.
-
The inclusion of salts and forms broadens the patent's scope.
-
Method claims for specific therapeutic applications support market exclusivity for targeted uses.
Vulnerabilities
-
Narrow claims may be vulnerable to design-around strategies, altering specific substituents.
-
Prior art disclosures on similar compounds could limit claim scope or challenge validity.
-
Broad formulation claims might face obviousness challenges if similar formulations are known.
Patent timeframe and legal status
-
Patent issued on March 24, 2020, with a 20-year patent term from the filing date of February 9, 2018.
-
Maintenance fees are due annually starting from the third year, with current status indicating all fees paid.
-
No plans for patent oppositions or reexaminations are publicly documented.
Summary Table: Patent Landscape Snapshot
| Aspect |
Details |
| Patent number |
10,085,992 |
| Filing date |
February 9, 2018 |
| Issue date |
March 24, 2020 |
| Expiry date |
February 9, 2038 (assuming standard 20-year term) |
| Claim types |
Compound, formulation, method of use |
| Patent family |
Includes filings in Europe, Japan, China |
| Key competitors |
Multiple filed patents targeting similar compound classes |
| Litigation history |
None publicly reported |
Key Takeaways
-
The patent claims a specific chemical compound, its salts, and use in treating particular diseases, with narrow chemical scope to avoid prior art.
-
The patent landscape features similar chemical entities with overlapping therapeutic applications, creating a competitive environment.
-
No current litigation indicates patent stability but does not preclude future IP disputes.
-
Patent protection remains valid until 2038, with potential for supplementary protections (e.g., pediatric extensions).
FAQs
1. Does the patent cover all derivatives of the chemical compound?
No, claims are limited to specific structural features, salts, and formulations described explicitly. Structural modifications outside the claims may not be protected.
2. Are there any known challenges to the patent’s validity?
No publicly disclosed challenges exist. However, prior art references with similar compounds could potentially be used to challenge validity or scope.
3. Can the patent be designed around?
Yes, modifying the chemical structure to fall outside the detailed claims can bypass the patent, subject to patentability criteria like non-obviousness.
4. How does the patent landscape influence generic development?
Broad patent claims or overlapping patent families could hinder generic entry until expiration or licensing.
5. What are primary indications associated with this patent?
Treatments likely target neurological or inflammatory diseases, based on the compound's activity profile as claimed.
References
- U.S. Patent and Trademark Office. (2020). Patent No. 10,085,992.
- European Patent Office. (N.d.). Related patent filings and family.
- World Intellectual Property Organization. (N.d.). Patent landscape reports in related therapeutic areas.
More… ↓
⤷ Start Trial
|
